ABSTRACT: BACKGROUND: The aim of this study was to perform a longitudinal assessment using Quantitative Muscle Testing (QMT) in a cohort of ambulant boys affected by Duchenne muscular dystrophy (DMD) and to correlate the results of QMT with functional measures. This study is to date the most thorough long-term evaluation of QMT in a cohort of DMD patients correlated with other measures, such as the North Star Ambulatory Assessment (NSAA) or thee 6-min walk test (6MWT). METHODS: This is a single centre, prospective, non-randomised, study assessing QMT using the Kin Com(R) 125 machine in a study cohort of 28 ambulant DMD boys, aged 5 to 12 years. This cohort was assessed longitudinally over a 12 months period of time with 3 monthly assessment...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
While the number of new treatment options tested in patients with Duchenne muscular dystrophy (DMD) ...
Objective: The aim of this study was to perform a longitudinal assessment using Quantitative Muscl...
Abstract Background The aim of this study was to perform a longitudinal assessment using Quantitativ...
Background: The aim of this study was to perform a longitudinal assessment using Quantitative Muscle...
Objective: The aim of the study was to assess different outcome measures in a cohort of ambulant boy...
The development of new therapeutic agents for the treatment of Duchenne muscular dystrophy has put a...
The purpose of this study was to quantitate motor performance in 196 genetically confirmed steroid-n...
Neuromuscular disorders are characterised by progressive muscle weakness, which in time causes funct...
BACKGROUND: Grip strength is used to infer functional status in several pathological conditions, and...
Objective: The aim of this study was to evaluate the usefulness of magnetic resonance imaging (MRI) ...
<div><p>The 6 minute walk test has been recently chosen as the primary outcome measure in internatio...
Background and Purpose: Duchenne muscular dystrophy (DMD) is a progressive neurodegenerative disease...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
While the number of new treatment options tested in patients with Duchenne muscular dystrophy (DMD) ...
Objective: The aim of this study was to perform a longitudinal assessment using Quantitative Muscl...
Abstract Background The aim of this study was to perform a longitudinal assessment using Quantitativ...
Background: The aim of this study was to perform a longitudinal assessment using Quantitative Muscle...
Objective: The aim of the study was to assess different outcome measures in a cohort of ambulant boy...
The development of new therapeutic agents for the treatment of Duchenne muscular dystrophy has put a...
The purpose of this study was to quantitate motor performance in 196 genetically confirmed steroid-n...
Neuromuscular disorders are characterised by progressive muscle weakness, which in time causes funct...
BACKGROUND: Grip strength is used to infer functional status in several pathological conditions, and...
Objective: The aim of this study was to evaluate the usefulness of magnetic resonance imaging (MRI) ...
<div><p>The 6 minute walk test has been recently chosen as the primary outcome measure in internatio...
Background and Purpose: Duchenne muscular dystrophy (DMD) is a progressive neurodegenerative disease...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
While the number of new treatment options tested in patients with Duchenne muscular dystrophy (DMD) ...